A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Clinical trial NCT04808505 · RECRUITING

Trial details

NCT number: NCT04808505
Sponsor: Amicus Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glycogen Storage Disease Type II Infantile Onset

Start date: 2023-07-18
Primary completion: 2027-07-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.